UGGT1 retains proinsulin in the endoplasmic reticulum in an arginine dependent manner.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
30 06 2020
Historique:
received: 10 04 2020
accepted: 30 04 2020
pubmed: 20 5 2020
medline: 20 1 2021
entrez: 20 5 2020
Statut: ppublish

Résumé

We sought to clarify a pathway by which L- and dD-arginine simulate insulin secretion in mice and cell lines and obtained the following novel two findings. (1) Using affinity magnetic nanobeads technology, we identified that proinsulin is retained in the endoplasmic reticulum (ER) through UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) when arginine availability is limited. (2) L- and d-arginine release proinsulin from UGGT1 through competition with proinsulin and promote exit of proinsulin from the ER to Golgi apparatus. The ability of arginine to release proinsulin from UGGT1 closely correlates with arginine-induced insulin secretion in several models of β cells indicating that UGGT1-proinsulin interaction regulates arginine-induced insulin secretion.

Identifiants

pubmed: 32423812
pii: S0006-291X(20)30903-7
doi: 10.1016/j.bbrc.2020.04.158
pmc: PMC7863631
mid: NIHMS1661560
pii:
doi:

Substances chimiques

Proinsulin 9035-68-1
Arginine 94ZLA3W45F
Glucosyltransferases EC 2.4.1.-
UGGT1 protein, mouse EC 2.4.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

668-675

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK054759
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK090490
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no competing financial interests.

Références

G3 (Bethesda). 2015 Jun 24;5(8):1737-49
pubmed: 26109356
BMC Genomics. 2014 Jul 22;15:620
pubmed: 25051960
Physiol Rev. 2018 Jan 1;98(1):117-214
pubmed: 29212789
Biochem Biophys Res Commun. 2013 Sep 27;439(3):413-7
pubmed: 23954637
Am J Physiol Endocrinol Metab. 2014 Nov 1;307(9):E800-12
pubmed: 25205820
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4052-60
pubmed: 27354520
Mol Metab. 2017 May 04;6(9):958-973
pubmed: 28951821
PLoS One. 2013 Sep 06;8(9):e73866
pubmed: 24040099
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15040-4
pubmed: 17855560
Mol Cell. 2005 Nov 23;20(4):503-12
pubmed: 16307915
Nature. 2002 Mar 14;416(6877):199-202
pubmed: 11894099
Diabetes Obes Metab. 2018 Sep;20 Suppl 2:28-50
pubmed: 30230185
Biochim Biophys Acta. 2007 Jun;1768(6):1479-87
pubmed: 17397797
Diabetes. 2012 Apr;61(4):828-37
pubmed: 22357960
Nature. 2016 Aug 11;536(7615):229-33
pubmed: 27487210
Vitam Horm. 2014;95:35-62
pubmed: 24559913
Sci Rep. 2017 Sep 22;7(1):12142
pubmed: 28939828
Mol Metab. 2017 Jul 08;6(9):943-957
pubmed: 28951820
Dis Model Mech. 2014 Mar;7(3):331-41
pubmed: 24609034
J Neurochem. 2003 Apr;85(2):476-82
pubmed: 12675924
Cell. 1999 Feb 5;96(3):329-39
pubmed: 10025399
Biochemistry. 2000 Mar 7;39(9):2149-63
pubmed: 10694380
Mol Metab. 2016 Dec 21;6(2):185-193
pubmed: 28180060
Diabetes. 2008 Jun;57(6):1618-28
pubmed: 18390794
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8544-8549
pubmed: 28739903
Biochem Biophys Res Commun. 2015 Oct 30;466(4):717-22
pubmed: 26348775
Biomed Chromatogr. 2010 Jun;24(6):606-12
pubmed: 19810004
Cell. 2016 Mar 24;165(1):153-164
pubmed: 26972053
Diabetes Care. 1994 Sep;17(9):1015-21
pubmed: 7988299

Auteurs

Jaeyong Cho (J)

Department Aging Intervention, National Center for Geriatrics and Gerontology, Obu, Aichi, 474-8511, Japan. Electronic address: jaeyong420@gmail.com.

Masaki Hiramoto (M)

Department Aging Intervention, National Center for Geriatrics and Gerontology, Obu, Aichi, 474-8511, Japan; Department of Biochemistry, Tokyo Medical University, Shinjyuku, Tokyo 160-8402, Japan. Electronic address: hiramoto@tokyo-med.ac.jp.

Yuka Masaike (Y)

Department of Nanoparticle Translational Research, Tokyo Medical University, Shinjyuku, Tokyo, 160-8402, Japan. Electronic address: yukamasaike@gmail.com.

Satoshi Sakamoto (S)

School of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Kanagawa, 223-8503, Japan. Electronic address: ssakamoto@bio.titech.ac.jp.

Yoichi Imai (Y)

Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, 108-8639, Japan. Electronic address: imaiyo-tky@umin.ac.jp.

Yumi Imai (Y)

Department of Internal Medicine, Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA. Electronic address: yumi-imai@uiowa.edu.

Hiroshi Handa (H)

Department of Nanoparticle Translational Research, Tokyo Medical University, Shinjyuku, Tokyo, 160-8402, Japan. Electronic address: hhanda@tokyo-med.ac.jp.

Takeshi Imai (T)

Department Aging Intervention, National Center for Geriatrics and Gerontology, Obu, Aichi, 474-8511, Japan. Electronic address: timai@ncgg.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH